Enid M. Eslick
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 16, 2022
Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma.
Journal: EJNMMI physics
Published: April 19, 2021
Quantitative PET in the 2020s: a roadmap.
Journal: Physics in medicine and biology
Published: December 18, 2020
Overlooked potential of positrons in cancer therapy.
Journal: Scientific reports
Published: October 13, 2020
Performance evaluation of quantitative SPECT/CT using NEMA NU 2 PET methodology.
Journal: Physics in medicine and biology
Published: June 18, 2019
SPECT V/Q in Lung Cancer Radiotherapy Planning.
Journal: Seminars in nuclear medicine
Published: December 14, 2018
A Comparison of 2D and 3D Kidney Absorbed Dose Measures in Patients Receiving 177Lu-DOTATATE.
Journal: Asia Oceania journal of nuclear medicine & biology
Published: July 13, 2018
CT ventilation imaging derived from breath hold CT exhibits good regional accuracy with Galligas PET.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 13, 2017
The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis.
Journal: Journal of human hypertension
Published: November 02, 2016
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.
Journal: Theranostics
Published: October 24, 2016
Last Updated: 09/26/2026